Cite
HARVARD Citation
Rivkin, S. et al. (2019). Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients. International journal of gynecological cancer. 29 (2), pp. 325-333. [Online].